[EXCLUSIVE] Little Vials, Big Crime: Criminals Primed For Onslaught On Africa’s Vaccines 11/02/2021 Darren Taylor/Bhekisisa Weak medicine regulators in Africa mean the continent is vulnerable to falsified COVID vaccines being circulated. Sources at international anti-crime agencies argue that Africa’s strong trade routes with China and India are going to allow criminals to introduce shipments of falsified vaccines into supply chains. The World Health Organisation says the global market for substandard […] Continue reading -> Okonjo-Iweala: Access To COVID-19 Vaccines ‘Not Just Moral Imperative – It Is A Strategic And Economic One’ 09/02/2021 Madeleine Hoecklin In her first major public statement since the United States signaled that it would approve her candidacy for Director-General of the World Trade Organization (WTO), Ngozi Okonjo-Iweala highlighted the need for rich countries to step up their financial contributions to ensure equitable access to COVID-19 tools. Okonjo-Iweala was the keynote speaker on Tuesday at the […] Continue reading -> AstraZeneca’s Failure in South African Trial Has Serious Implications for Broader African COVID-19 Vaccine Rollout 08/02/2021 Kerry Cullinan CAPE TOWN – The failure of the Oxford/ AstraZeneca SARS-COV2 vaccine to protect against the COVID-19 variant identified in South Africa has serious implications for massive African vaccine rollouts planned by both the WHO co-sponsored COVAX vaccine facility as well as the African Union’s dedicated African Vaccine Acquisition Task Team (AVATT). The bulk of Africa’s […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> South Africa’s Second COVID Wave Passes Despite Variant – AstraZeneca Vaccines For Health Workers’ Arrive But At Higher Price Than EU Paid 02/02/2021 Kerry Cullinan CAPE TOWN – Despite battling against a more infectious variant, South Africa seems to have ridden out its second and deadliest wave of COVID-19 infections. And with new case counts declining, the government relaxed its most recent set of lockdown restrictions on Tuesday – reopening beaches, and easing night-time curfews and a ban on alcohol […] Continue reading -> Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> Pharma Ill-Equipped To Handle 10 Most Infectious Diseases And Future Pandemics, Report Warns 29/01/2021 Raisa Santos With ten of the world’s most infectious diseases not catered by drug firms, pharmaceutical giants remain unprepared to tackle future pandemics, a new report has said. The report, published on Tuesday, found that though current medicine and vaccine research and development is primarily geared towards the COVID-19 pandemic, there are next to no efforts to […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Pfizer/BioNTech Join Global COVAX Vaccine Facility – In Game-Changer For WHO Plan To Roll Out Vaccines More Equitably 22/01/2021 Elaine Ruth Fletcher Pfizer/BioNTech will join the WHO-co-sponsored COVAX vaccine facility, providing up to 40 million vaccines at cost to the Facility for use in low-income countries around the world – in what signals a breakthrough for the facility that only a week ago appeared to be teetering on the verse of irrelevance – as more low- and […] Continue reading -> Posts navigation Older postsNewer posts
Okonjo-Iweala: Access To COVID-19 Vaccines ‘Not Just Moral Imperative – It Is A Strategic And Economic One’ 09/02/2021 Madeleine Hoecklin In her first major public statement since the United States signaled that it would approve her candidacy for Director-General of the World Trade Organization (WTO), Ngozi Okonjo-Iweala highlighted the need for rich countries to step up their financial contributions to ensure equitable access to COVID-19 tools. Okonjo-Iweala was the keynote speaker on Tuesday at the […] Continue reading -> AstraZeneca’s Failure in South African Trial Has Serious Implications for Broader African COVID-19 Vaccine Rollout 08/02/2021 Kerry Cullinan CAPE TOWN – The failure of the Oxford/ AstraZeneca SARS-COV2 vaccine to protect against the COVID-19 variant identified in South Africa has serious implications for massive African vaccine rollouts planned by both the WHO co-sponsored COVAX vaccine facility as well as the African Union’s dedicated African Vaccine Acquisition Task Team (AVATT). The bulk of Africa’s […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> South Africa’s Second COVID Wave Passes Despite Variant – AstraZeneca Vaccines For Health Workers’ Arrive But At Higher Price Than EU Paid 02/02/2021 Kerry Cullinan CAPE TOWN – Despite battling against a more infectious variant, South Africa seems to have ridden out its second and deadliest wave of COVID-19 infections. And with new case counts declining, the government relaxed its most recent set of lockdown restrictions on Tuesday – reopening beaches, and easing night-time curfews and a ban on alcohol […] Continue reading -> Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> Pharma Ill-Equipped To Handle 10 Most Infectious Diseases And Future Pandemics, Report Warns 29/01/2021 Raisa Santos With ten of the world’s most infectious diseases not catered by drug firms, pharmaceutical giants remain unprepared to tackle future pandemics, a new report has said. The report, published on Tuesday, found that though current medicine and vaccine research and development is primarily geared towards the COVID-19 pandemic, there are next to no efforts to […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Pfizer/BioNTech Join Global COVAX Vaccine Facility – In Game-Changer For WHO Plan To Roll Out Vaccines More Equitably 22/01/2021 Elaine Ruth Fletcher Pfizer/BioNTech will join the WHO-co-sponsored COVAX vaccine facility, providing up to 40 million vaccines at cost to the Facility for use in low-income countries around the world – in what signals a breakthrough for the facility that only a week ago appeared to be teetering on the verse of irrelevance – as more low- and […] Continue reading -> Posts navigation Older postsNewer posts
AstraZeneca’s Failure in South African Trial Has Serious Implications for Broader African COVID-19 Vaccine Rollout 08/02/2021 Kerry Cullinan CAPE TOWN – The failure of the Oxford/ AstraZeneca SARS-COV2 vaccine to protect against the COVID-19 variant identified in South Africa has serious implications for massive African vaccine rollouts planned by both the WHO co-sponsored COVAX vaccine facility as well as the African Union’s dedicated African Vaccine Acquisition Task Team (AVATT). The bulk of Africa’s […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> South Africa’s Second COVID Wave Passes Despite Variant – AstraZeneca Vaccines For Health Workers’ Arrive But At Higher Price Than EU Paid 02/02/2021 Kerry Cullinan CAPE TOWN – Despite battling against a more infectious variant, South Africa seems to have ridden out its second and deadliest wave of COVID-19 infections. And with new case counts declining, the government relaxed its most recent set of lockdown restrictions on Tuesday – reopening beaches, and easing night-time curfews and a ban on alcohol […] Continue reading -> Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> Pharma Ill-Equipped To Handle 10 Most Infectious Diseases And Future Pandemics, Report Warns 29/01/2021 Raisa Santos With ten of the world’s most infectious diseases not catered by drug firms, pharmaceutical giants remain unprepared to tackle future pandemics, a new report has said. The report, published on Tuesday, found that though current medicine and vaccine research and development is primarily geared towards the COVID-19 pandemic, there are next to no efforts to […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Pfizer/BioNTech Join Global COVAX Vaccine Facility – In Game-Changer For WHO Plan To Roll Out Vaccines More Equitably 22/01/2021 Elaine Ruth Fletcher Pfizer/BioNTech will join the WHO-co-sponsored COVAX vaccine facility, providing up to 40 million vaccines at cost to the Facility for use in low-income countries around the world – in what signals a breakthrough for the facility that only a week ago appeared to be teetering on the verse of irrelevance – as more low- and […] Continue reading -> Posts navigation Older postsNewer posts
Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> South Africa’s Second COVID Wave Passes Despite Variant – AstraZeneca Vaccines For Health Workers’ Arrive But At Higher Price Than EU Paid 02/02/2021 Kerry Cullinan CAPE TOWN – Despite battling against a more infectious variant, South Africa seems to have ridden out its second and deadliest wave of COVID-19 infections. And with new case counts declining, the government relaxed its most recent set of lockdown restrictions on Tuesday – reopening beaches, and easing night-time curfews and a ban on alcohol […] Continue reading -> Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> Pharma Ill-Equipped To Handle 10 Most Infectious Diseases And Future Pandemics, Report Warns 29/01/2021 Raisa Santos With ten of the world’s most infectious diseases not catered by drug firms, pharmaceutical giants remain unprepared to tackle future pandemics, a new report has said. The report, published on Tuesday, found that though current medicine and vaccine research and development is primarily geared towards the COVID-19 pandemic, there are next to no efforts to […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Pfizer/BioNTech Join Global COVAX Vaccine Facility – In Game-Changer For WHO Plan To Roll Out Vaccines More Equitably 22/01/2021 Elaine Ruth Fletcher Pfizer/BioNTech will join the WHO-co-sponsored COVAX vaccine facility, providing up to 40 million vaccines at cost to the Facility for use in low-income countries around the world – in what signals a breakthrough for the facility that only a week ago appeared to be teetering on the verse of irrelevance – as more low- and […] Continue reading -> Posts navigation Older postsNewer posts
South Africa’s Second COVID Wave Passes Despite Variant – AstraZeneca Vaccines For Health Workers’ Arrive But At Higher Price Than EU Paid 02/02/2021 Kerry Cullinan CAPE TOWN – Despite battling against a more infectious variant, South Africa seems to have ridden out its second and deadliest wave of COVID-19 infections. And with new case counts declining, the government relaxed its most recent set of lockdown restrictions on Tuesday – reopening beaches, and easing night-time curfews and a ban on alcohol […] Continue reading -> Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> Pharma Ill-Equipped To Handle 10 Most Infectious Diseases And Future Pandemics, Report Warns 29/01/2021 Raisa Santos With ten of the world’s most infectious diseases not catered by drug firms, pharmaceutical giants remain unprepared to tackle future pandemics, a new report has said. The report, published on Tuesday, found that though current medicine and vaccine research and development is primarily geared towards the COVID-19 pandemic, there are next to no efforts to […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Pfizer/BioNTech Join Global COVAX Vaccine Facility – In Game-Changer For WHO Plan To Roll Out Vaccines More Equitably 22/01/2021 Elaine Ruth Fletcher Pfizer/BioNTech will join the WHO-co-sponsored COVAX vaccine facility, providing up to 40 million vaccines at cost to the Facility for use in low-income countries around the world – in what signals a breakthrough for the facility that only a week ago appeared to be teetering on the verse of irrelevance – as more low- and […] Continue reading -> Posts navigation Older postsNewer posts
Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> Pharma Ill-Equipped To Handle 10 Most Infectious Diseases And Future Pandemics, Report Warns 29/01/2021 Raisa Santos With ten of the world’s most infectious diseases not catered by drug firms, pharmaceutical giants remain unprepared to tackle future pandemics, a new report has said. The report, published on Tuesday, found that though current medicine and vaccine research and development is primarily geared towards the COVID-19 pandemic, there are next to no efforts to […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Pfizer/BioNTech Join Global COVAX Vaccine Facility – In Game-Changer For WHO Plan To Roll Out Vaccines More Equitably 22/01/2021 Elaine Ruth Fletcher Pfizer/BioNTech will join the WHO-co-sponsored COVAX vaccine facility, providing up to 40 million vaccines at cost to the Facility for use in low-income countries around the world – in what signals a breakthrough for the facility that only a week ago appeared to be teetering on the verse of irrelevance – as more low- and […] Continue reading -> Posts navigation Older postsNewer posts
European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> Pharma Ill-Equipped To Handle 10 Most Infectious Diseases And Future Pandemics, Report Warns 29/01/2021 Raisa Santos With ten of the world’s most infectious diseases not catered by drug firms, pharmaceutical giants remain unprepared to tackle future pandemics, a new report has said. The report, published on Tuesday, found that though current medicine and vaccine research and development is primarily geared towards the COVID-19 pandemic, there are next to no efforts to […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Pfizer/BioNTech Join Global COVAX Vaccine Facility – In Game-Changer For WHO Plan To Roll Out Vaccines More Equitably 22/01/2021 Elaine Ruth Fletcher Pfizer/BioNTech will join the WHO-co-sponsored COVAX vaccine facility, providing up to 40 million vaccines at cost to the Facility for use in low-income countries around the world – in what signals a breakthrough for the facility that only a week ago appeared to be teetering on the verse of irrelevance – as more low- and […] Continue reading -> Posts navigation Older postsNewer posts
Pharma Ill-Equipped To Handle 10 Most Infectious Diseases And Future Pandemics, Report Warns 29/01/2021 Raisa Santos With ten of the world’s most infectious diseases not catered by drug firms, pharmaceutical giants remain unprepared to tackle future pandemics, a new report has said. The report, published on Tuesday, found that though current medicine and vaccine research and development is primarily geared towards the COVID-19 pandemic, there are next to no efforts to […] Continue reading -> UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Pfizer/BioNTech Join Global COVAX Vaccine Facility – In Game-Changer For WHO Plan To Roll Out Vaccines More Equitably 22/01/2021 Elaine Ruth Fletcher Pfizer/BioNTech will join the WHO-co-sponsored COVAX vaccine facility, providing up to 40 million vaccines at cost to the Facility for use in low-income countries around the world – in what signals a breakthrough for the facility that only a week ago appeared to be teetering on the verse of irrelevance – as more low- and […] Continue reading -> Posts navigation Older postsNewer posts
UK COVID-19 Variant: US Official ‘Convinced’ Of Increased Mortality Despite ‘Uncertain’ Evidence 25/01/2021 J Hacker Michael Osterholm – a leading member of the United States President’s coronavirus transition team – has said he is “convinced” by data indicating the UK COVID-19 variant is more deadly, even as United Kingdom officials downplay the limited and “uncertain” evidence. Meanwhile, Moderna announced today that it will “test an additional booster dose of its […] Continue reading -> Pfizer/BioNTech Join Global COVAX Vaccine Facility – In Game-Changer For WHO Plan To Roll Out Vaccines More Equitably 22/01/2021 Elaine Ruth Fletcher Pfizer/BioNTech will join the WHO-co-sponsored COVAX vaccine facility, providing up to 40 million vaccines at cost to the Facility for use in low-income countries around the world – in what signals a breakthrough for the facility that only a week ago appeared to be teetering on the verse of irrelevance – as more low- and […] Continue reading -> Posts navigation Older postsNewer posts
Pfizer/BioNTech Join Global COVAX Vaccine Facility – In Game-Changer For WHO Plan To Roll Out Vaccines More Equitably 22/01/2021 Elaine Ruth Fletcher Pfizer/BioNTech will join the WHO-co-sponsored COVAX vaccine facility, providing up to 40 million vaccines at cost to the Facility for use in low-income countries around the world – in what signals a breakthrough for the facility that only a week ago appeared to be teetering on the verse of irrelevance – as more low- and […] Continue reading -> Posts navigation Older postsNewer posts